$0.5176
0.02234.5%
Last update: Nov 9, 7:00 AM
Aprea Therapeutics Inc
APRENASDAQ
The average analyst price target for Aprea Therapeutics is $2.80, 418.5% above the current price. Of 4 analysts, 4 rate it Buy. Targets range from $1.20 to $5. The latest change came on Oct 14, 2026, when Ladenburg Thalmann initiated coverage of Aprea Therapeutics with a Buy rating and a $2 price target.
Price Target Range — 10 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
